Australia · Delayed Price · Currency is AUD ReNerve Statistics
Total Valuation
ReNerve has a market cap or net worth of AUD 21.32 million. The enterprise value is 16.56 million.
| Market Cap | 21.32M |
| Enterprise Value | 16.56M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ReNerve has 170.54 million shares outstanding. The number of shares has increased by 30.31% in one year.
| Current Share Class | 170.54M |
| Shares Outstanding | 170.54M |
| Shares Change (YoY) | +30.31% |
| Shares Change (QoQ) | +35.83% |
| Owned by Insiders (%) | 28.87% |
| Owned by Institutions (%) | 2.26% |
| Float | 86.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 78.46 |
| PB Ratio | 4.10 |
| P/TBV Ratio | 4.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.44 |
| EV / Sales | 60.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.46 |
Financial Position
The company has a current ratio of 6.31
| Current Ratio | 6.31 |
| Quick Ratio | 5.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.85 |
Financial Efficiency
Return on equity (ROE) is -148.79% and return on invested capital (ROIC) is -89.31%.
| Return on Equity (ROE) | -148.79% |
| Return on Assets (ROA) | -72.18% |
| Return on Invested Capital (ROIC) | -89.31% |
| Return on Capital Employed (ROCE) | -85.13% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.47% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 63.64 |
| Average Volume (20 Days) | 516,235 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ReNerve had revenue of AUD 271,707 and -3.73 million in losses. Loss per share was -0.03.
| Revenue | 271,707 |
| Gross Profit | 244,666 |
| Operating Income | -4.45M |
| Pretax Income | -3.73M |
| Net Income | -3.73M |
| EBITDA | -4.41M |
| EBIT | -4.45M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 4.75 million in cash and n/a in debt, with a net cash position of 4.75 million or 0.03 per share.
| Cash & Cash Equivalents | 4.75M |
| Total Debt | n/a |
| Net Cash | 4.75M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 5.20M |
| Book Value Per Share | 0.04 |
| Working Capital | 5.11M |
Cash Flow
In the last 12 months, operating cash flow was -2.98 million and capital expenditures -48,428, giving a free cash flow of -3.03 million.
| Operating Cash Flow | -2.98M |
| Capital Expenditures | -48,428 |
| Free Cash Flow | -3.03M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | 90.05% |
| Operating Margin | -1,639.23% |
| Pretax Margin | -1,374.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ReNerve does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.31% |
| Shareholder Yield | -30.31% |
| Earnings Yield | -17.52% |
| FCF Yield | -14.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ReNerve has an Altman Z-Score of 7.13 and a Piotroski F-Score of 1.
| Altman Z-Score | 7.13 |
| Piotroski F-Score | 1 |